Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study
- PMID: 2127604
- DOI: 10.1007/BF01130591
Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study
Abstract
In order to diminish the cancellation rate due to a premature endogeneous LH surge and/or to a poor ovarian response and thus increasing the pregnancy rate, a GnRH agonist (Buserelin) was applied in patients starting their first ovarian stimulation with gonadotropins for IVF. All patients suffered from tubal infertility and were not older than 40 years. Each woman was allocated randomly to one of three groups: the conventional treatment with hMG alone (group I), patients from group II started the hMG treatment shortly after the LH rise caused by the GnRH agonist and patients in group III commenced the hMG treatment when an hypogonadotropic state was achieved after a long treatment of Buserelin. All male partners had a normal spermiogram. A reduction of poor responders to the superovulation is seen in the short-term group (6%), compared with the other two groups (14%). In some cases from group III ovarian cyst formation led to the cancellation of the treatment. The long-term group differs significantly from the other two in the duration of the gonadotropin stimulation and the number of ampoules hMG used. A severe ovarian overstimulation syndrome was not observed. There is no difference in the number of retrieved oocytes and the fertilization rate among the three groups. The pregnancy rate per cycle or per patient in the group with a short-term GnRH-agonist regimen is significantly higher compared to that of the group using the conventional hMG treatment.
Similar articles
-
GnRH agonist administration in polycystic ovary syndrome.Clin Endocrinol (Oxf). 1989 Aug;31(2):151-65. doi: 10.1111/j.1365-2265.1989.tb01238.x. Clin Endocrinol (Oxf). 1989. PMID: 2514053
-
In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.J Assist Reprod Genet. 1997 Oct;14(9):503-7. doi: 10.1023/a:1021171225322. J Assist Reprod Genet. 1997. PMID: 9401867 Free PMC article.
-
Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome?Gynecol Endocrinol. 1995 Jun;9(2):91-6. doi: 10.3109/09513599509160196. Gynecol Endocrinol. 1995. PMID: 7502695
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
-
Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins.Hum Reprod Update. 1998 Jan-Feb;4(1):83-101. doi: 10.1093/humupd/4.1.83. Hum Reprod Update. 1998. PMID: 9622415 Review.
Cited by
-
Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.J Assist Reprod Genet. 1992 Jun;9(3):254-8. doi: 10.1007/BF01203824. J Assist Reprod Genet. 1992. PMID: 1525457
-
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2. Cochrane Database Syst Rev. 2025. PMID: 40590303 Review.
-
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.Cochrane Database Syst Rev. 2015 Nov 9;2015(11):CD006919. doi: 10.1002/14651858.CD006919.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Jan 9;1:CD006919. doi: 10.1002/14651858.CD006919.pub5. PMID: 26558801 Free PMC article. Updated.
-
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5. Cochrane Database Syst Rev. 2025. PMID: 39783453
-
Effectiveness of the postcoital test: randomised controlled trial.BMJ. 1998 Aug 22;317(7157):502-5. doi: 10.1136/bmj.317.7157.502. BMJ. 1998. PMID: 9712594 Free PMC article. Clinical Trial.